{
  "disease_name": "Plasma cell leukemia",
  "synonyms": [
    "PCL",
    "Primary plasma cell leukemia",
    "pPCL",
    "Secondary plasma cell leukemia",
    "sPCL"
  ],
  "summary": "Plasma cell leukemia (PCL) is a plasma cell dyscrasia, a malignant degeneration of plasma cells. It is the most aggressive form of plasma cell malignancies, occurring either primarily or secondary to multiple myeloma. PCL is a serious, life-threatening, and therapeutically challenging disease.",
  "causes": [
    "Development of excessively high number of genetic abnormalities in plasma cells or their precursor B cells and plasmablasts",
    "Acquired genetic abnormalities including gene mutations, single nucleotide polymorphisms, deletions and duplications of gene parts or chromosomes, translocations, and changes in gene expression",
    "Abnormalities affecting Wnt signaling pathway, cell cycle regulation, RNA metabolism, protein folding, and cell adherence"
  ],
  "risk_factors": [],
  "symptoms": [
    "Splenomegaly",
    "Lymphadenopathy",
    "Hepatomegaly",
    "Kidney failure",
    "Bone marrow failure (thrombocytopenia, anemia, leukopenia)",
    "Central nervous system defects",
    "Peripheral neuropathies",
    "Hypercalcemic crisis",
    "High levels of serum lactate dehydrogenase",
    "High levels of Beta-2 microglobulin",
    "Soft tissue plasma cell tumors (plasmacytomas)"
  ],
  "diagnosis": [
    "Presence of >2 billion plasma cells per liter of blood",
    "Presence of >20% of nucleated blood cells being plasma cells",
    "Flow cytometry immunophenotyping of blood cells to detect clonal phenotypes of plasma cells (e.g., CD138+, CD38+, CD19âˆ’, CD45+/- phenotype)"
  ],
  "treatments": [
    "VAD regimen (vincristine, doxorubicin, dexamethasone)",
    "VCMP regimen (vincristine, carmustine, melphalan, prednisone alternating with vincristine, carmustine, doxorubicin, prednisone)",
    "Proteasome inhibitor drugs (bortezomib, ixazomib, carfilzomib)",
    "Autologous stem-cell transplantation",
    "Immunomodulator agents (thalidomide, lenalidomide, pomalidomide)",
    "Dexamethasone (corticosteroid)"
  ],
  "related_genes": [],
  "subtypes": [
    "Primary plasma cell leukemia (pPCL)",
    "Secondary plasma cell leukemia (sPCL)"
  ]
}